<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJEMD</journal-id><journal-title-group><journal-title>Open Journal of Endocrine and Metabolic Diseases</journal-title></journal-title-group><issn pub-type="epub">2165-7424</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojemd.2018.81006</article-id><article-id pub-id-type="publisher-id">OJEMD-81912</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Effect of Binge Drinking on Glucose Metabolism in Occasional Drinkers: An Experimental Study
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nawé</surname><given-names>Justine Astrid Ngandeu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Armand</surname><given-names>Mbanya</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Eric</surname><given-names>Lontchi-Yimagou</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Vicky</surname><given-names>Kamwa</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean</surname><given-names>Louis Nguewa</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean-Claude</surname><given-names>Katte</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Andrea</surname><given-names>Michèle Audrey Omengue</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Simeon-Pierre</surname><given-names>Choukem</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mesmin</surname><given-names>Dehayem</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jean-Claude</surname><given-names>Mbanya</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Eugene</surname><given-names>Sobngwi</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Diabetes Research and Training Center and Division of Endocrinology, Department of Medicine, Albert Einstein College of Medicine, New York, NY, USA</addr-line></aff><aff id="aff6"><addr-line>Department of Internal Medicine, Faculty of Medicine and Biomedical Sciences, University of Yaoundé, Yaoundé, Cameroon</addr-line></aff><aff id="aff4"><addr-line>Yaounde Central Hospital, National Obesity Center, Yaoundé, Cameroon</addr-line></aff><aff id="aff1"><addr-line>Cocody’s CHU, Abidjan, Ivory Coast</addr-line></aff><aff id="aff7"><addr-line>Departments of Internal Medicine and Pediatrics, Faculty of Health Sciences, University of Buea, Buea, Cameroon</addr-line></aff><aff id="aff3"><addr-line>Laboratories of Molecular Medicine and Metabolism, Biotechnology Center, University of Yaoundé, Yaoundé, Cameroon</addr-line></aff><aff id="aff5"><addr-line>Inserm UMRS 1138, Cordeliers Research Centre, University of Paris, Paris, France</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>ngandeuastrid@yahoo.fr(NJAN)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>02</day><month>01</month><year>2018</year></pub-date><volume>08</volume><issue>01</issue><fpage>49</fpage><lpage>58</lpage><history><date date-type="received"><day>23,</day>	<month>December</month>	<year>2017</year></date><date date-type="rev-recd"><day>19,</day>	<month>January</month>	<year>2018</year>	</date><date date-type="accepted"><day>22,</day>	<month>January</month>	<year>2018</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Binge drinking is a major public health problem that affects all age groups. Its relation to the risk of impaired glucose metabolism and diabetes is unclear due to controversial findings in animal models and lack of studies in humans. We performed an experimental study on 10 adult volunteers (7M/3F) under the age of 40 who were occasional binge drinkers. In all participants, we performed a baseline two-hour euglycemic hyperinsulinemic clamp at 80 mU
  &amp;bull;m
  <sup>&amp;minus;2</sup>
  &amp;bull;min
  <sup>&amp;minus;1</sup> at baseline for comparison with an age and sex matched control population of non-drinkers. On a second occasion, before and after ingestion of 78 g of alcohol (beer) in 2 hrs we also measured insulin sensitivity using a 15-minute short insulin tolerance test in drinkers. Blood glucose was also measured every 15 mins over 2 hours during alcohol ingestion. Volunteers were aged 27.6 &#177; 5.7 years, with a BMI of 23.1 &#177; 2.8 kg/m
  <sup>2</sup>, and ALAT of 24.7 &#177; 3.0 UI/L. Insulin sensitivity evaluated by the clamp technique was higher in occasional drinkers (M = 12.7 &#177; 3.4 mg
  &amp;bull;kg
  <sup>&amp;minus;1</sup>
  &amp;bull;min
  <sup>&amp;minus;1</sup> vs. 8.0 &#177; 2.3 mg
  &amp;bull;kg
  <sup>&amp;minus;1</sup>
  &amp;bull;min
  <sup>&amp;minus;1</sup> in non-drinkers, p = 0.011). Acute alcohol ingestion was associated with a non-significant trends towards improved glucose disappearance during short insulin tolerance test (KITT 2.53% &#177; 0.22%/min before vs. 3.11% &#177; 1.15%/min after; p = 0.122). Beer consumption induced a significant increase in capillary glycaemia of 78% (p = 0.001). Bingeing was associated with reduced insulin secretion (Homa-
  <em>β</em> 113.5 &#177; 22.7 vs. 155.4 &#177; 57.6; p = 0.047). Binge drinking may induce an increase in insulin sensitivity but acutely decrease insulin secretion.
 
</p></abstract><kwd-group><kwd>Glucose Metabolism</kwd><kwd> Binge Drinking</kwd><kwd> Insulin Sensitivity</kwd><kwd> Insulin Secretion</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Alcohol is the third highest risk factor for morbidity and mortality after hypertension and smoking. It is a known etiological factor for over 200 diseases [<xref ref-type="bibr" rid="scirp.81912-ref1">1</xref>] . The most frequent drinking pattern is binge drinking, but epidemiological studies have mostly focused on chronic alcohol consumption. Binge drinking is defined as the consumption of 4 or more drinks containing alcohol on the same occasion for a woman; and five or more drinks on one occasion in a man over a period of about 2 hours [<xref ref-type="bibr" rid="scirp.81912-ref2">2</xref>] . Binge drinking is a public health problem and is linked to an increased incidence in type 2 diabetes and metabolic syndrome, however, the mechanism by which binge drinking affects glucose metabolism remains unclear [<xref ref-type="bibr" rid="scirp.81912-ref3">3</xref>] . This increased incidence with binge drinking has been attributed to increased insulin resistance. Alcohol may directly induce insulin resistance or may be linked to increased caloric intake as a result of alterations in central reward pathways [<xref ref-type="bibr" rid="scirp.81912-ref4">4</xref>] . Chronic alcohol consumption is known to affect insulin secretion but little is known about binge drinking. Most evidence to date is derived from animal studies, limited data exist in humans associating binge drinking to impaired glucose metabolism. We therefore evaluated the acute effects of binge drinking on glucose metabolism, specifically glycaemic profile during binge drinking, insulin sensitivity and insulin secretion.</p></sec><sec id="s2"><title>2. Methods</title><p>1) Study Population</p><p>We carried out an experimental study at the Clinical Investigation Unit of the Department of Endocrinology and Metabolic disease of Yaound&#233; Central Hospital, Yaound&#233; (Cameroon). We enrolled by advertisement 10 young adults (7 males and 3 females) reporting a habit of binge drinking at least once a week for the past year with a reported minimum of 4 glasses for females or 5 glasses for males in a session (average alcohol consumption was 72.9 &#177; 7.8 g/occasion). Desire to stop alcohol consumption, obesity, coexisting disease, the use of any medication that could have an effect insulin sensitivity or secretion, variation in weight ≥ 10% during the 3months prior to the study, acute alcohol consumption less than 3days prior to study, elevated fasting capillary glycaemia, recent infection less than ten days prior to inclusion, high hepatic transaminase ALAT (3 &#215; normal) and creatinine clearance ≤ 60 ml/min/1.73m&#178; were exclusion criteria. The 10 test volunteers were compared to age and sex matched 10 control volunteers reporting no alcohol consumption. The sample size was calculated from an expected change of insulin sensitivity of at least 20% from baseline in drinker. Choosing α at 5%, β at 20%, and a statistical power of 80%, the calculated sample size is 10 subjects. The study protocol was approved by the Institutional Research Ethical Committee of the Faculty of Medicine and Biomedical Sciences Yaound&#233; and by the institutional review board of the Yaound&#233; Central Hospital.</p><p>2) Procedure</p><p>After collecting lifestyle and background data and performing clinical examination, we measured baseline insulin sensitivity by an 80 m・Um<sup>−2</sup>・min<sup>−1</sup> euglycemic-hyperinsulinemic clamp. Pre- and post-intervention insulin sensitivity was measured using the short insulin tolerance test.</p><p>a) Euglycemic-Hyperinsulinemic Clamp</p><p>After overnight fast of at least 8 hours, rapid insulin (Actrapid<sup>&#174;</sup> HM Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark) in a syringe pump (ALARIS<sup>&#174;</sup> MEDICAL SYSTEMS UK Ltd., Basingstoke, RG22 4BS, UK) and 10% dextrose solution were infused via the right anterior cubital vein using an infusion pump (IVAC Corporation-Model 598, San Diego, California). Blood sampling was done through the left anterior cubital vein. A priming infusion of insulin was given over the first 10 minutes followed by a constant supraphysiological infusion rate of 80 mU・m<sup>−2</sup>・min<sup>−1</sup> until the 120th minute. Dextrose infusion rate was adjusted every 5 minutes with the aim of maintaining capillary blood sugar levels at 5.5 &#177; 0.5 mmol/L (My Life<sup>&#174;</sup> Pura<sup>&#174;</sup> Ypsomed Ltd., CH-3401 Burgdorf/Switzerland). Insulin sensitivity was calculated at the steady state by the M-value (mg・kg<sup>-1</sup>・min<sup>-1</sup>) which represents glucose disposal rate during insulin infusion and was adjusted to lean body mass [<xref ref-type="bibr" rid="scirp.81912-ref5">5</xref>] .</p><p>b) Short Insulin Tolerance Test and Binge Drinking Test</p><p>Following an overnight fast, an intravenous injection of 0.15 UI/kg of insulin (Actrapid<sup>&#174;</sup> HM Novo Nordisk A/S 2880 Bagsvaerd, Denmark), diluted in 2cc of isotonic saline was done. Capillary glycemia was measured before and at the 3rd, 6th, 9th, 12th, and 15th minute after injection. Short insulin tolerance test (SITT)-derived insulin sensitivity was calculated by the slope of the linear drop in blood glucose (KITT) by dividing 0.693 by the half-life of the drop in blood sugar. One hour after the first SITT, the volunteers ingested 78 g of alcohol over 2 hours. Capillary blood glucose was measured every 15 minutes during alcohol consumption. At the end of the 2-hour period, the insulin tolerance test was repeated.</p><p>3) Analytical Methods</p><p>Glucose was analyzed by the glucose oxidase method. Lipid profile was determined by enzymatic colorimetric methods. Fat mass and BMI was evaluated using electrical bio-impedance. C-peptide levels were measured by enzyme linked immunosorbent assay (ELISA) with the IBL C-peptide Enzyme Immunoassay Kit from Mercodia<sup>&#174;</sup> (Mercodia AB, Sylveniusgatan 8A, SE-754 50, Uppsala, Sweden) which had been previously validated in our laboratory functional sensitivity of 0.32 &#181;g/L. The inter- and intra-assay % CV were 2.9% - 9.9%, and 5.2% - 9.4%, respectively [<xref ref-type="bibr" rid="scirp.81912-ref6">6</xref>] . Homa-β was calculated using the following formula: 0.27 &#215; fasting C-peptide/(fasting glycemia-3.5 mmol) + 50 to estimate insulin secretion.</p><p>Results were expressed as mean &#177; SD. Means were compared between groups with the Student’s test and Fischer’s exact test. Graphs were made in graph pad prism software version 5. KITTs and M values were calculated using predesigned excel sheets from our previous study [<xref ref-type="bibr" rid="scirp.81912-ref6">6</xref>] . A p value &lt; 0.05 was considered statistically significant for all analyses.</p></sec><sec id="s3"><title>3. Results</title><p>1) General Characteristics of the Study Population</p><p>We had 15 volunteers at the start, having responded to our invitation, but only 10 who presented themselves. We had a response rate of about 67%. They consisted of 7 men and 3 women. Their mean age was 28 &#177; 6 years. Our study population consisted of two groups; binge drinkers and non-drinkers of alcohol. <xref ref-type="table" rid="table1">Table 1</xref> shows the baseline characteristics of our study population. Binge drinkers had higher diastolic blood pressure than non-drinkers (p = 0.014).</p><p>2) Baseline Insulin Sensitivity and Insulin Secretion</p><p>During the euglycemic hyperinsulinemic clamp, glucose uptake (M value) was 12.7 &#177; 3 mg・kg<sup>−1</sup>・min<sup>−1</sup> in drinkers vs. 8.1 &#177; 2.3 mg・kg<sup>−1</sup>・min<sup>−1</sup> in non-drinkers (p = 0.011). Similar trends remained after adjustment for body lean mass (M = 15.0 &#177; 3.3 vs. 10 &#177; 2.0 mg・kg<sup>−1</sup>・min<sup>−1</sup>; p = 0.007) as shown in <xref ref-type="table" rid="table1">Table 1</xref>. There was no difference in C-peptide levels which is the marker for insulin secretion in both groups but Homa-β was lower in drinkers (p = 0.047). The relation between insulin sensitivity and insulin secretion is showed in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p><p>3) Metabolic Effect of Ingestion 78 g of Alcohol over 2 hrs</p><p>Alcohol (beer) was ingested for two hours during which blood sugar levels rose significantly (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="table" rid="table2">Table 2</xref>). The insulin sensitivity of the volunteers increased by about 23% after ingesting alcohol (KITT = 2.53 &#177; 0.22 %/min before vs. 3.11 &#177; 1.15 %/min after; p = 0.122).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Baseline characteristics of participants</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Subjects</th><th align="center" valign="middle" >Controls</th><th align="center" valign="middle" >p</th></tr></thead><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >10 (F = 3; M = 7)</td><td align="center" valign="middle" >08 (F = 3; M = 5)</td><td align="center" valign="middle" >-</td></tr><tr><td align="center" valign="middle" >Ages (ann&#233;es)</td><td align="center" valign="middle" >28 &#177; 6</td><td align="center" valign="middle" >28 &#177; 5</td><td align="center" valign="middle" >0.78</td></tr><tr><td align="center" valign="middle" >TT en cm</td><td align="center" valign="middle" >78.2 &#177; 7.6</td><td align="center" valign="middle" >82.0 &#177; 12.1</td><td align="center" valign="middle" >0.469</td></tr><tr><td align="center" valign="middle" >TH en cm</td><td align="center" valign="middle" >85.6 &#177; 7.9</td><td align="center" valign="middle" >94.0 &#177; 11.0</td><td align="center" valign="middle" >0.166</td></tr><tr><td align="center" valign="middle" >Rapport TT/TH</td><td align="center" valign="middle" >0.9 &#177; 0.3</td><td align="center" valign="middle" >0.9 &#177; 0.7</td><td align="center" valign="middle" >0.123</td></tr><tr><td align="center" valign="middle" >IMC en Kg/m&#178;</td><td align="center" valign="middle" >23.1 &#177; 2.9</td><td align="center" valign="middle" >24.5 &#177; 4.4</td><td align="center" valign="middle" >0.459</td></tr><tr><td align="center" valign="middle" >masse grasse en %</td><td align="center" valign="middle" >15.3 &#177; 5.0</td><td align="center" valign="middle" >19.3 &#177; 10.3</td><td align="center" valign="middle" >0.216</td></tr><tr><td align="center" valign="middle" >PAS en mmHg</td><td align="center" valign="middle" >122 &#177; 10</td><td align="center" valign="middle" >115 &#177; 7</td><td align="center" valign="middle" >0.154</td></tr><tr><td align="center" valign="middle" >PAD en mmHg</td><td align="center" valign="middle" >78 &#177; 8</td><td align="center" valign="middle" >68 &#177; 6</td><td align="center" valign="middle" >0.014</td></tr><tr><td align="center" valign="middle" >PAM en mmHg</td><td align="center" valign="middle" >93 &#177; 8</td><td align="center" valign="middle" >84 &#177; 5</td><td align="center" valign="middle" >0.027</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Insuline sensitivity before and after taking alcohol</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Subjects</th><th align="center" valign="middle" >KITT before</th><th align="center" valign="middle" >KITT after</th><th align="center" valign="middle" >Difference</th><th align="center" valign="middle" >p for glycemia before/after</th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.741 %/min</td><td align="center" valign="middle" >3.14 %/min</td><td align="center" valign="middle" >0.399 %/min</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.316 %/min</td><td align="center" valign="middle" >2.949 %/min</td><td align="center" valign="middle" >0.633 %/min</td><td align="center" valign="middle" >0.04</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >2.432 %/min</td><td align="center" valign="middle" >5.001 %/min</td><td align="center" valign="middle" >2.569 %/min</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.462 %/min</td><td align="center" valign="middle" >3.3 %/min</td><td align="center" valign="middle" >0.838 %/min</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >5</td><td align="center" valign="middle" >2.401 %/min</td><td align="center" valign="middle" >2.069 %/min</td><td align="center" valign="middle" >−0.332 %/min</td><td align="center" valign="middle" >0.27</td></tr><tr><td align="center" valign="middle" >6</td><td align="center" valign="middle" >2.527 %/min</td><td align="center" valign="middle" >1.852 %/min</td><td align="center" valign="middle" >−0.675 %/min</td><td align="center" valign="middle" >0.195</td></tr><tr><td align="center" valign="middle" >7</td><td align="center" valign="middle" >2.862 %/min</td><td align="center" valign="middle" >3.09 %/min</td><td align="center" valign="middle" >0.228 %/min</td><td align="center" valign="middle" >0.174</td></tr><tr><td align="center" valign="middle" >8</td><td align="center" valign="middle" >2.343 %/min</td><td align="center" valign="middle" >2.025 %/min</td><td align="center" valign="middle" >−0.318 %/min</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >2.372 %/min</td><td align="center" valign="middle" >2.56 %/min</td><td align="center" valign="middle" >0.188 %/min</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >2.905 %/min</td><td align="center" valign="middle" >5.133 %/min</td><td align="center" valign="middle" >2.228 %/min</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >Mean</td><td align="center" valign="middle" >2.54 &#177; 0.22 %/min</td><td align="center" valign="middle" >3.11 &#177; 1.15 %/min</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >0.122</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><p>The aim of our study was to evaluate the effects of acute alcohol consumption on glucose metabolism in the occasional binge drinker. Our results demonstrate that in the study population, binge drinking is associated with an acute increase in insulin sensitivity and a 36.7% reduction in insulin secretion. The consumption of 78 g of alcohol in the form of beer acutely induces a progressive increase in glycemia of about 78%, along with an improvement in the insulin sensitivity of 22.9%. Binge drinking is the most common way of alcohol consumption in the world and yet is little studied in terms of glucose metabolism. The majority of work focuses on chronic alcohol consumption. In order to assess insulin sensitivity at base line, we performed the euglycemic hyperinsulinemic clamp technique which is the gold standard [<xref ref-type="bibr" rid="scirp.81912-ref7">7</xref>] . Measuring variations of insulin sensitivity requires an accurate and reproducible technique; it was done by the short test of tolerance to insulin, which has the advantage of a good correlation with the clamp [<xref ref-type="bibr" rid="scirp.81912-ref8">8</xref>] . The beer brand Guinness&#174; as type of alcohol was chosen after a survey amongst volunteers, and allows for the reproducibility of the test, in a wide range of countries Insulin secretion was measured based on Homa-β using fasting C-peptide levels.</p><p>Epidemiological studies on alcohol consumption with regard to type 2 diabetes are controversial. Findings have varied, with non-alcohol consumers presenting with a higher relative risk vs. alcohol consumers [<xref ref-type="bibr" rid="scirp.81912-ref9">9</xref>] . Nakanishi in 2003 in a cohort studied for 7 years, based on the principle of a U-shaped relationship between alcohol and type 2 diabetes implying that moderate alcohol consumption reduces the risk of glucose intolerance and diabetes type 2 in healthy Japanese [<xref ref-type="bibr" rid="scirp.81912-ref10">10</xref>] . In patients previously intolerant to glucose, alcohol can worsen this condition [<xref ref-type="bibr" rid="scirp.81912-ref11">11</xref>] . The work of Cullman and collaborators in 2012 [<xref ref-type="bibr" rid="scirp.81912-ref12">12</xref>] show that binge drinking by a high consumption of beer increases the risk of pre-diabetes in both sexes; and consumption of large amounts of wine and spirits reduces the risk of diabetes in women.</p><p>Glucose intolerance is caused by a variable association between insulin sensitivity and insulin secretion. In order to understand the relationship between alcohol and the occurrence of type 2 diabetes, a detailed assessment of these two parameters must be carried out. With respect to insulin sensitivity, we found that M-value adjusted for lean mass in occasional binge drinkers was higher than in controls revealing higher insulin sensitivity. Similarly, there was an increase in the KITT after bingeing in our study. Facchini et al. in 1994, had similar results in individuals who usually moderate alcohol consumption (30 g) evaluating their insulin sensitivity by oral glucose tolerance test. His findings indicated that moderate consumers of alcohol have insulin sensitivity better than that of controls [<xref ref-type="bibr" rid="scirp.81912-ref13">13</xref>] . The improved insulin sensitivity in binge drinkers may be explained in several ways. The waist circumference and percentage of fat mass though not significant of subjects in our study is lower which may indicate less abdominal fat than in controls hence higher insulin sensitivity. These results are in agreement with those of Schlienger et al. in 2008 show that the favorable relationship between alcohol consumption and the insulin sensitivity could be mediated in part by the impact of alcohol on abdominal obesity [<xref ref-type="bibr" rid="scirp.81912-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.81912-ref15">15</xref>] . Furthermore, it is understood that reducing the early peak of insulin secretion leads to loss of inhibition of hepatic glucose production in response to a meal and an elevation of postprandial glucose [<xref ref-type="bibr" rid="scirp.81912-ref16">16</xref>] . In animal models, binge drinking induces an increase in the suppression of hepatic glucose production, which could explain the improvement of insulin sensitivity observed in the acute drinkers. Animal studies, stipulate that the main mechanism of binge drinking on glucose metabolism is by inducing whole-body insulin resistance by impairing hypothalamic insulin action but not liver insulin signaling [<xref ref-type="bibr" rid="scirp.81912-ref17">17</xref>] . In addition, bingeing is known to induce oxidative stress as a result of alcohol metabolism [<xref ref-type="bibr" rid="scirp.81912-ref18">18</xref>] and increases expression and processing of cytokines and chemokines, recruiting and accumulation of inflammatory cells and macrophage oxidative capacity particularly in adipose tissue [<xref ref-type="bibr" rid="scirp.81912-ref19">19</xref>] . This may account for adipose tissue resistance to alcohol. Globally, the acute effects of binge drinking on insulin sensitivity remain controversial.</p><p>Though our findings suggest an acute improvement in insulin sensitivity, it is necessary to follow people who binge over time to determine of the findings in animal models develop at a later time post-bingeing. Insulin secretion in the alcohol consumer, irrespective of the mode of consumption has been scantily studied. We found a reduced insulin secretion in chronic binge drinkers. Alcohol has known deleterious effects on the pancreas which may explain this decrease in insulin secretion. Also alcohol induces systemic elevation of cathecholamines leading to activation of lipolytic enzymes [<xref ref-type="bibr" rid="scirp.81912-ref20">20</xref>] and decreasing insulin secretion. Insulin secretion shares an important relationship with insulin sensitivity. Indeed, in non-diabetic subjects, insulin resistance is compensated by an increase in insulin secretion and vice versa. Our results show that the volunteers who had a very good sensitivity to insulin, paradoxically have reduced insulin secretion; which confirms the inverse relationship presented by Ahren et al. [<xref ref-type="bibr" rid="scirp.81912-ref21">21</xref>] . Though we did not measure hepatic glucose production, in animal models, a hyperinsulinemic euglycemic clamp with tracer shows that in binge model rats, the suppression of hepatic glucose production is statistically higher than in control rats (96% vs. 74%). We can conclude that binge drinking is linked to prolonged impairment of glucose metabolism [<xref ref-type="bibr" rid="scirp.81912-ref11">11</xref>] . It is known that regular alcohol consumption is harmful to the liver. Transaminases may not be increased when the liver is already suffering. Among the volunteers, 100% had normal transaminases, and 50% of them increased GGT values. We found no correlation between the amount of alcohol and the occasional normal values; although, there is a negative correlation between GGT and value M. This would mean that the more gamma GT values are high, the more insulin sensitivity is low, and therefore the damage induced by alcohol to the liver has a deleterious effect on insulin sensitivity. Regarding the effects of alcohol on blood sugar, you should know that it is affected by the energy value of the alcohol consumed and its total carbohydrates content per volume consumed. With this property, by its composition (Glycemic Index = 110) as cited in the literature it is not surprising that we found an increase in blood sugar of around 78% in two hours ingestion of beer.</p></sec><sec id="s5"><title>5. Summary</title><p>The metabolic effects of binge drinking seem to be favorable when considering the sensitivity to insulin. It is unlikely that this is the result of a reduced risk of diabetes given the observed decrease in insulin secretion. Though, our results suggest this, there are multiple health risks and negative effects of alcohol consumption irrespective of the mode of consumption hence it should not be used in an abusive manner.</p></sec><sec id="s6"><title>Competing Interest</title><p>The authors have no conflict of interest to declare.</p></sec><sec id="s7"><title>Authors’ Contribution</title><p>ANN: researched, analyzed and interpreted data, drafted the manuscript. AM: researched data, drafted, reviewed and edited the manuscript. VK: researched data. OTD: analyzed data. ELY: researched data. JLN: Researched data. JCM and ES: Designed the study, interpreted data, reviewed and edited the manuscript. All authors read and approved the final manuscript.</p></sec><sec id="s8"><title>Acknowledgements</title><p>We show our sincere gratitude to the patients who participated in this study and to the nursing and laboratory staff at the National Obesity Centre, Yaound&#233;, Cameroon.</p></sec><sec id="s9"><title>Cite this paper</title><p>Ngandeu, N.J.A., Mbanya, A., Lontchi-Yimagou, E., Kamwa, V., Nguewa, J.L., Katte, J.-C., Omengue, A.M.A., Choukem, S.-P., Dehayem, M., Mbanya, J.-C. and Sobngwi, E. (2018) Effect of Binge Drinking on Glucose Metabolism in Occasional Drinkers: An Experimental Study. Open Journal of Endocrine and Metabolic Diseases, 8, 49-58. https://doi.org/10.4236/ojemd.2018.81006</p></sec></body><back><ref-list><title>References</title><ref id="scirp.81912-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">O’Keefe, J.H., Bhatti, S.K., Bajwa, A., DiNicolantonio, J.J. and Lavie, C.J. (2014) Alcohol and Cardiovascular Health: The Dose Makes the Poison...or the Remedy. Mayo Clinic Proceedings, 89, 382-393. https://doi.org/10.1016/j.mayocp.2013.11.005</mixed-citation></ref><ref id="scirp.81912-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Blazer, D.G. and Wu, L.T. (2009) The Epidemiology of At-Risk and Binge Drinking among Middle-Aged and Elderly Community Adults: National Survey on Drug Use and Health. The American Journal of Psychiatry, 166, 1162-1169. https://doi.org/10.1176/appi.ajp.2009.09010016</mixed-citation></ref><ref id="scirp.81912-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Naimi, T.S., Brewer, R.D., Mokdad, A., Denny, C., Serdula, M.K. and Marks, J.S. (2003) BInge Drinking among US Adults. JAMA, 289, 70-75. https://doi.org/10.1001/jama.289.1.70</mixed-citation></ref><ref id="scirp.81912-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Thiele, T.E. (2013) Insulin Resistance from Binge Drinking: It’s All in Your Head. Science Translational Medicine, 5, 170fs3. https://doi.org/10.1126/scitranslmed.3005300</mixed-citation></ref><ref id="scirp.81912-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Volkow, N.D., Wang, G.J. and Baler, R.D. (2011) Reward, Dopamine and the Control of Food Intake: Implications for Obesity. Trends in Cognitive Sciences, 15, 37-46. https://doi.org/10.1016/j.tics.2010.11.001</mixed-citation></ref><ref id="scirp.81912-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Mbanya, A., Ngandeu, A., Kamwa, V., Donfack, O.T., Lontchi, é., Leke, R., Mbanya, J.-C. and Sobngwi, E. (2016) Metabolic Features Associated with Positivity to ZnT8 Autoantibody in Sub-Saharan African Young-Onset Diabetes Patients. Diabetes &amp; Metabolism, 42, 204-206. https://doi.org/10.1016/j.diabet.2015.12.002</mixed-citation></ref><ref id="scirp.81912-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">De Fronzo, R.A., Tobin, J.D. and Andres, R. (1979) Glucose Clamp Technique: A Method for Quantifying Insulin Secretion and Resistance. The American Journal of Physiology, 237, E214-E223.</mixed-citation></ref><ref id="scirp.81912-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Gelding, S.V., Robinson, S., Lowe, S., Niththyananthan, R. and Johnston, D.G. (1994) Validation of the Low Dose Short Insulin Tolerance Test for Evaluation of Insulin Sensitivity. Clinical Endocrinology, 40, 611-615. https://doi.org/10.1111/j.1365-2265.1994.tb03012.x</mixed-citation></ref><ref id="scirp.81912-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Wei, M., Gibbons, L.W., Mitchell, T.L., Kampert, J.B. and Blair, S.N. (2000) Alcohol Intake and Incidence of Type 2 Diabetes in Men. Diabetes Care, 23, 18-22. https://doi.org/10.2337/diacare.23.1.18</mixed-citation></ref><ref id="scirp.81912-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Nakanishi, N., Suzuki, K. and Tatara, K. (2003) Alcohol Consumption and Risk for Development of Impaired Fasting Glucose or Type 2 Diabetes in Middle-Aged Japanese Men. Diabetes Care, 26, 48-54. https://doi.org/10.2337/diacare.26.1.48</mixed-citation></ref><ref id="scirp.81912-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Lindtner, C., Scherer, T., Zielinski, E., Filatova, N., Fasshauer, M., Tonks, N.K., et al. (2013) Binge Drinking Induces Whole-Body Insulin Resistance by Impairing Hypothalamic Insulin Action. Science Translational Medicine, 5, 170ra14. https://doi.org/10.1126/scitranslmed.3005123</mixed-citation></ref><ref id="scirp.81912-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Cullmann, M., Hilding, A. and Ostenson, C.G. (2012) Alcohol Consumption and Risk of Pre-Diabetes and Type 2 Diabetes Development in a Swedish Population. Diabetic Medicine: A Journal of the British Diabetic Association, 29, 441-452. https://doi.org/10.1111/j.1464-5491.2011.03450.x</mixed-citation></ref><ref id="scirp.81912-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Facchini, F., Chen, Y.D. and Reaven, G.M. (1994) Light-to-Moderate Alcohol Intake Is Associated with Enhanced Insulin Sensitivity. Diabetes Care, 17, 115-119. https://doi.org/10.2337/diacare.17.2.115</mixed-citation></ref><ref id="scirp.81912-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Schlienger, J.L., Pradignac, A. and Vinzio, S. (2008) Alcool, métabolisme glucique et diabète. Sang Thrombose Vaisseaux, 20, 13-18.</mixed-citation></ref><ref id="scirp.81912-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Leggio, L., Malandrino, N., Ferrulli, A., Cardone, S., Miceli, A., Gasbarrini, G., et al. (2009) Is Cortisol Involved in the Alcohol-Related Fat Mass Impairment? A Longitudinal Clinical Study. Alcohol and Alcoholism, 44, 211-215. https://doi.org/10.1093/alcalc/agn116</mixed-citation></ref><ref id="scirp.81912-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Caumo, A. and Luzi, L. (2004) First-Phase Insulin Secretion: Does It Exist in Real Life? Considerations on Shape and Function. American Journal of Physiology, 287, E371-E385.</mixed-citation></ref><ref id="scirp.81912-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Garcia-Ruiz, C. and Fernandez-Checa, J.C. (2013) To Binge or Not to Binge: Binge Drinking Disrupts Glucose Homeostasis by Impairing Hypothalamic But Not Liver Insulin Signaling. Hepatology, 57, 2535-2538. https://doi.org/10.1002/hep.26423</mixed-citation></ref><ref id="scirp.81912-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Tang, H., Sebastian, B.M., Axhemi, A., Chen, X., Hillian, A.D., Jacobsen, D.W., et al. (2012) Ethanol-Induced Oxidative Stress via the CYP2E1 Pathway Disrupts Adiponectin Secretion from Adipocytes. Alcoholism, Clinical and Experimental Research, 36, 214-222. https://doi.org/10.1111/j.1530-0277.2011.01607.x</mixed-citation></ref><ref id="scirp.81912-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Qin, Y., Hamilton, J.L., Bird, M.D., Chen, M.M., Ramirez, L., Zahs, A., et al. (2014) Adipose Inflammation and Macrophage Infiltration after Binge Ethanol and Burn Injury. Alcoholism, Clinical and Experimental Research, 38, 204-213. https://doi.org/10.1111/acer.12210</mixed-citation></ref><ref id="scirp.81912-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, C., Liu, Y., Xiao, J., Liu, L., Chen, S., Mohammadi, M., et al. (2015) FGF21 Mediates Alcohol-Induced Adipose Tissue Lipolysis by Activation of Systemic Release of Catecholamine in Mice. Journal of Lipid Research, 56, 1481-1491. https://doi.org/10.1194/jlr.M058610</mixed-citation></ref><ref id="scirp.81912-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Ahren, B. and Pacini, G. (2004) Importance of Quantifying Insulin Secretion in Relation to Insulin Sensitivity to Accurately Assess Beta Cell Function in Clinical Studies. European Journal of Endocrinology/European Federation of Endocrine Societies, 150, 97-104. https://doi.org/10.1530/eje.0.1500097</mixed-citation></ref></ref-list></back></article>